Endostemonine I as a Multi-Target Inhibitor of Kaposi’s Sarcoma-Associated Herpesvirus Oncogenic Pathways: An Integrative Computational Study
Imran Sama-ae, Mollaya Daloh, Aman Tedasen, Siriruk Changrob, Monthon Lertcanawanichakul, Pattamaporn Kwankaew, Phenphitcha Issaro, Natthanicha Maidam, Nichakan Rattanapong, Nurul Auma, Mirfart Kaseng, Malatee Tayeh · 2026
Read Endostemonine I as a Multi-Target Inhibitor of Kaposi’s Sarcoma-Associated Herpesvirus Oncogenic Pathways: An Integrative Computational Study by Imran Sama-ae, Mollaya Daloh, Aman Tedasen, Siriruk Changrob, Monthon Lertcanawanichakul, Pattamaporn Kwankaew, Phenphitcha Issaro, Natthanicha Maidam, Nichakan Rattanapong, Nurul Auma, Mirfart Kaseng, Malatee Tayeh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13214889.txt.
Description
Imran Sama-ae and a large team of co-authors report, in a 2026 computer study, a candidate drug against Kaposi's sarcoma, a cancer driven by a herpesvirus. The disease mixes runaway blood vessel growth, lasting inflammation, and cell change, so a drug that hits several targets at once looks more promising than a single-target one. Few such agents exist for this cancer.
The team screened compounds from Streptomyces bacteria with a joined pipeline: target guessing, network mapping, and docking simulations. One compound, endostemonine I, came out on top, engaging nine of ten hub proteins. Those hubs include drivers of vessel growth and inflammation. Motion simulations checked that the binding holds steady. All results are in silico, and lab tests would come next.
Catalog record
| CREATOR | Imran Sama-ae, Mollaya Daloh, Aman Tedasen, Siriruk Changrob, Monthon Lertcanawanichakul, Pattamaporn Kwankaew, Phenphitcha Issaro, Natthanicha Maidam, Nichakan Rattanapong, Nurul Auma, Mirfart Kaseng, Malatee Tayeh |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |